Market Place
Sourcing Support
HotSpot Therapeutics Presents Data From MALT1 Glue Program
23 Oct 2024 //
PR NEWSWIRE
HotSpot Appoints Alison O`Neill As Chief Medical Officer
19 Sep 2024 //
PR NEWSWIRE
HotSpot Presents Phase 1 Data On CBL-B Inhibitor At ESMO 2024
12 Sep 2024 //
PR NEWSWIRE
HotSpot To Present Phase 1 Data On CBL-B Inhibitor At ESMO 2024
17 Jul 2024 //
PR NEWSWIRE
HotSpot Presents MALT1 Inhibitor Data At AACR Malignant Lymphoma Meeting
20 Jun 2024 //
PR NEWSWIRE
HotSpot Presents Data for Potential First-in-Class MALT1 Scaffolding Inhibitor
11 Dec 2023 //
PR NEWSWIRE
HotSpot Therapeutics to Introduce First-in-Class MALT1 Scaffolding Inhibitor
02 Nov 2023 //
PR NEWSWIRE
HotSpot Therapeutics Achieves First-In-Human Dosing with HST-1011
11 Apr 2023 //
PR NEWSWIRE
US FDA clears HotSpot Therapeutics’ IND application for HST-1011
03 Jan 2023 //
PHARMABIZ
AbbVie connects with HotSpot for $40M cash
06 Dec 2022 //
FIERCEBIOTECH
Excelra Partners with HotSpot to Enhance Allosteric Drug Discovery Efforts
25 May 2022 //
PRNEWSWIRE
HotSpot Tx Presents Pre-Clinical Data on CBL-B Program at AACR
08 Apr 2022 //
PRNEWSWIRE
Caris, HotSpot collaborate to advance precision medicine development
11 Jan 2022 //
PHARMABIZ
HotSpot gets hotter with $100M raise to push toward clinic
29 Nov 2021 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.